Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Q4 2022 Earnings Call Transcript
Operator: Greetings and welcome to the Processa Pharmaceuticals Year-End 2022 Earnings Call and Corporate Update. As a reminder, this call is being recorded.
Processa Pharmaceuticals Inc. (PCSA)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 15,770.5 | $105,536 | +90% | 0% |
| 2. | Renaissance Technologies Jim Simons | 2,910 | $19,000 | +8% | 0% |
| 3. | Millennium Management Israel Englander | 0 | $0 | -100% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.45 | 21,000 | 79,387 | 2024-02-07 | Filing | ||
| $2.53 | 20,000 | 58,387 | 2024-02-06 | Filing | ||
| $2.40 | 1,500 | 27,478 | 2024-02-01 | Filing | ||
| $2.37 | 2,500 | 25,978 | 2024-01-31 | Filing | ||
| $2.70 | 10,000 | 20,000 | 2024-01-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.30 | 1,854 | Director | 532,563 | 2022-01-27 | Filing | |
| $4.71 | 4,200 | Director | 534,417 | 2021-12-06 | Filing | |
| $4.84 | 5,500 | Director | 538,617 | 2021-12-03 | Filing | |
| $11.56 | 20,929 | Large Shareholder | 1,096,071 | 2021-02-22 | Filing | |
| $11.20 | 3,000 | Large Shareholder | 1,117,000 | 2021-02-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,732.65 | $78,515 | 0% | |
| 2. | 6,101.65 | $40,832 | 0% | |
| 3. | 4,001.15 | $26,808 | 0% | |
| 4. | 3,843.25 | $25,719 | 0% | |
| 5. | 2,315.3 | $15,000 | 0% |
News See All
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) Q3 2022 Earnings Call Transcript
Operator: Greetings, and welcome to Processa Pharmaceuticals third-quarter 2022 earnings call and corporate update. At this time, all participants are in a listen-only mode.
Is Processa Pharmaceuticals, Inc. (PCSA) A Good Stock To Buy?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.